查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612864

軟骨修復/軟骨再生市場：依治療模式、應用和最終用戶分類－2025-2030年全球預測

Cartilage Repair/Cartilage Regeneration Market by Treatment Mode (Cell-Based, Non-Cell-Based), Application (Fibrocartilage, Hyaline Cartilage), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年軟骨修復/軟骨再生市場價值為18.3億美元，預計2024年將達20.6億美元，複合年成長率為13.55%，到2030年將達到44.6億美元。

軟骨修復和再生需要受損軟骨組織的修復和再生，這對於關節功能和活動能力至關重要。骨關節炎、運動傷害和與老齡化相關的軟骨損傷的流行推動了對此類手術的需求，這些疾病影響著數百萬人，並推動了對有效治療的需求。典型應用包括自體軟骨細胞移植術、幹細胞治療和組織工程，最終使用者包括醫院、整形外科診所和研究機構。影響市場成長的主要因素包括再生醫學的進步、醫療保健支出的增加以及對微創手術意識的增強。特別是，世界人口老化以及對更有效、侵入性較小的治療的需求迅速增加，正在擴大該領域的機會。 3D 生物列印和生物工程支架的開發等技術創新是可促進產業顯著成長的潛在機會。然而，治療成本上漲、複雜的監管途徑和報銷問題等限制和挑戰限制了市場的擴張。由於經濟差異和缺乏熟練的專業人員，一些地區的採用率較低，這也加劇了這些挑戰。最有希望創新的領域包括開發具有成本效益和擴充性的治療方法以及提高修復的壽命和效率。企業應專注於持續調查方法，改進現有方法，並與學術和研究機構合作，保持在新發現的前沿。市場的本質是動態的，並由以患者為中心的創新和策略夥伴關係關係驅動，重點是個人化醫療。投資培訓計劃來應對人才挑戰並促進全球合作可以提高您的競爭力。透過解決這些限制並抓住新機遇，公司可以利用這個不斷成長的市場。

主要市場統計
基準年[2023] 18.3億美元
預計年份 [2024] 20.6億美元
預測年份 [2030] 44.6億美元
複合年成長率（%） 13.55%

市場動態：快速發展的軟骨修復/軟骨再生市場的關鍵市場洞察

軟骨修復/軟骨再生市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 關節炎、骨關節炎等骨關節疾病的流行
    • 交通事故和運動相關傷害迅速增加
    • 提高對軟骨生理學、解剖學和修復技術的認知
  • 市場限制因素
    • 軟骨修復手術相關的高成本
  • 市場機會
    • 軟骨再生設備的技術進步
    • 持續研究和開發軟骨再生
  • 市場挑戰
    • 與軟骨修復/軟骨再生手術相關的風險和併發症

波特的五力：引領軟骨修復/軟骨再生市場的策略工具

波特五力是了解軟骨修復/軟骨再生市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解軟骨修復/軟骨再生市場的外部影響

外部宏觀環境因素在塑造軟骨修復/軟骨再生市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解軟骨修復/軟骨再生市場的競爭狀況

對軟骨修復/軟骨再生市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣軟骨修復/軟骨再生市場廠商績效評估

FPNV定位矩陣是評估軟骨修復/軟骨再生市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製軟骨修復/軟骨再生市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對軟骨修復/軟骨再生市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 關節炎和骨關節炎等骨關節疾病的盛行率
      • 交通事故和運動相關傷害的數量正在迅速增加。
      • 提高對軟骨生理學、解剖學和修復技術的認知
    • 抑制因素
      • 軟骨修復手術相關的高成本
    • 機會
      • 軟骨再生裝置的技術進步
      • 持續研究和開發軟骨再生
    • 任務
      • 與軟骨修復/軟骨再生手術相關的風險和併發症
  • 市場區隔分析
    • 治療模式：年輕患者首選細胞治療方法
    • 應用：更廣泛地使用透明軟骨療法來實現有效的關節運動
    • 最終用戶：由於複雜手術所需的先進設備和材料的存在，軟骨修復/軟骨再生在醫院環境中的應用正在增加。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療模式分類的軟骨修復/軟骨再生市場

  • 基於細胞的
    • 軟骨細胞移植
    • 生長因子技術
  • 非細胞基礎
    • 無細胞複合材料
    • 組織支架

第7章軟骨修復/軟骨再生市場：依應用分類

  • 纖維軟骨
  • 透明軟骨

第8章軟骨修復/軟骨再生市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第9章 北美和南美軟骨修復/軟骨再生市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太軟骨修復/軟骨再生市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲軟骨修復/軟骨再生市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 全錄輝獲得用於運動醫學膝蓋修復的新軟骨再生技術
    • FDA核准CartiHeal植入用於治療軟骨和骨軟骨缺損
  • 戰略分析和建議

公司名單

  • Anika Therapeutics Inc.
  • Arthrex GmbH
  • B. Braun SE
  • Collagen Solutions Ltd.
  • CONMED Corporation
  • Geistlich Pharma AG
  • Medical Device Business Services, Inc.
  • MEDIPOST Co., Ltd.
  • Orthocell Ltd.
  • Regrow Biosciences Pvt Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4103B31E00C5

The Cartilage Repair/Cartilage Regeneration Market was valued at USD 1.83 billion in 2023, expected to reach USD 2.06 billion in 2024, and is projected to grow at a CAGR of 13.55%, to USD 4.46 billion by 2030.

Cartilage repair and regeneration involve restoring or regrowing damaged cartilage tissue, crucial for joint function and mobility. The necessity for these procedures stems from the prevalence of osteoarthritis, sports injuries, and cartilage damage due to aging, which affect millions and drive demand for effective treatments. Applications primarily include autologous chondrocyte implantation, stem cell therapy, and tissue engineering, with end-users comprising hospitals, orthopedic clinics, and research institutes. Key factors influencing market growth include advancements in regenerative medicine, increasing healthcare expenditure, and rising awareness of minimally invasive procedures. Notably, the aging global population and burgeoning demand for more effective and less invasive treatments are expanding opportunities in this field. Technological innovations, such as 3D bioprinting and the development of bioengineered scaffolds, are potential opportunities that can be leveraged for significant industry growth. However, limitations and challenges such as the high cost of treatments, complex regulatory pathways, and reimbursement issues constrain market expansion. The slow adoption rate in some regions due to economic disparities and lack of skilled professionals further compounds these challenges. The most promising areas for innovation include developing cost-effective, scalable treatments and enhancing the longevity and efficiency of repairs. Companies should focus on continuous R&D to improve existing methodologies and collaborate with academic and research organizations to stay at the forefront of new discoveries. The nature of the market is dynamic, driven by patient-centric innovations and strategic partnerships, with an emphasis on personalized medicine. Investing in training programs to address human resource challenges and fostering global collaborations can provide a competitive edge. By addressing these constraints and seizing emerging opportunities, businesses can capitalize on this growing market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.83 billion
Estimated Year [2024] USD 2.06 billion
Forecast Year [2030] USD 4.46 billion
CAGR (%) 13.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cartilage Repair/Cartilage Regeneration Market

The Cartilage Repair/Cartilage Regeneration Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of bone and joint disorders such as arthritis or osteoarthritis
    • Surge in number of road accidents and sports-related injuries
    • Rising awareness about cartilage physiology, anatomy, and repair techniques
  • Market Restraints
    • High costs associated with cartilage repair surgeries
  • Market Opportunities
    • Technological advancements in cartilage regeneration equipment
    • Continuous research and development for cartilage regeneration
  • Market Challenges
    • Risks and complications involved in cartilage repair/cartilage regeneration procedures

Porter's Five Forces: A Strategic Tool for Navigating the Cartilage Repair/Cartilage Regeneration Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cartilage Repair/Cartilage Regeneration Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cartilage Repair/Cartilage Regeneration Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cartilage Repair/Cartilage Regeneration Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cartilage Repair/Cartilage Regeneration Market

A detailed market share analysis in the Cartilage Repair/Cartilage Regeneration Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cartilage Repair/Cartilage Regeneration Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cartilage Repair/Cartilage Regeneration Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cartilage Repair/Cartilage Regeneration Market

A strategic analysis of the Cartilage Repair/Cartilage Regeneration Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex GmbH, B. Braun SE, Collagen Solutions Ltd., CONMED Corporation, Geistlich Pharma AG, Medical Device Business Services, Inc., MEDIPOST Co., Ltd., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cartilage Repair/Cartilage Regeneration Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Mode, market is studied across Cell-Based and Non-Cell-Based. The Cell-Based is further studied across Chondrocyte Transplantation and Growth Factor Technology. The Non-Cell-Based is further studied across Cell-Free Composites and Tissue Scaffolds.
  • Based on Application, market is studied across Fibrocartilage and Hyaline Cartilage.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of bone and joint disorders such as arthritis or osteoarthritis
      • 5.1.1.2. Surge in number of road accidents and sports-related injuries
      • 5.1.1.3. Rising awareness about cartilage physiology, anatomy, and repair techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cartilage repair surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cartilage regeneration equipment
      • 5.1.3.2. Continuous research and development for cartilage regeneration
    • 5.1.4. Challenges
      • 5.1.4.1. Risks and complications involved in cartilage repair/cartilage regeneration procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Mode: Significant preference cell-based therapies for younger patients
    • 5.2.2. Application: Wider use of hyaline cartilage therapies for efficient joint movement
    • 5.2.3. End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cartilage Repair/Cartilage Regeneration Market, by Treatment Mode

  • 6.1. Introduction
  • 6.2. Cell-Based
    • 6.2.1. Chondrocyte Transplantation
    • 6.2.2. Growth Factor Technology
  • 6.3. Non-Cell-Based
    • 6.3.1. Cell-Free Composites
    • 6.3.2. Tissue Scaffolds

7. Cartilage Repair/Cartilage Regeneration Market, by Application

  • 7.1. Introduction
  • 7.2. Fibrocartilage
  • 7.3. Hyaline Cartilage

8. Cartilage Repair/Cartilage Regeneration Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Cartilage Repair/Cartilage Regeneration Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair
    • 12.3.2. FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anika Therapeutics Inc.
  • 2. Arthrex GmbH
  • 3. B. Braun SE
  • 4. Collagen Solutions Ltd.
  • 5. CONMED Corporation
  • 6. Geistlich Pharma AG
  • 7. Medical Device Business Services, Inc.
  • 8. MEDIPOST Co., Ltd.
  • 9. Orthocell Ltd.
  • 10. Regrow Biosciences Pvt Ltd.
  • 11. RTI Surgical, Inc.
  • 12. Smith & Nephew PLC
  • 13. Stryker Corporation
  • 14. Vericel Corporation
  • 15. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
  • FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023